Alseres Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1972-01-01
- Employees
- 3
- Market Cap
- -
- Website
- http://www.alseres.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor
- First Posted Date
- 2008-07-30
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- Alseres Pharmaceuticals, Inc
- Target Recruit Count
- 240
- Registration Number
- NCT00724906
- Locations
- 🇺🇸
Alseres Pharmaceuticals, Inc, Hopkinton, Massachusetts, United States
123I-ALTROPANE® Reference Image Acquisition in Subjects With Diagnostically Uncertain Tremor
Completed
- Conditions
- Upper Extremity Tremor
- First Posted Date
- 2008-01-17
- Last Posted Date
- 2009-05-29
- Lead Sponsor
- Alseres Pharmaceuticals, Inc
- Target Recruit Count
- 54
- Registration Number
- NCT00596908
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸University of Arizona, Tucson, Arizona, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
News
No news found